RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX)

Historical Holders from Q1 2019 to Q3 2025

Symbol
RXRX on Nasdaq
CUSIP
75629V104
Type / Class
Equity / Common Stock
Shares outstanding
4.56M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
324M
Holdings value
$1.58B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
313
Number of buys
170
Number of sells
-124
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARK Investment Management LLC 8.47% $186M 32.3M ARK Investment Management LLC Dec 31, 2024
BlackRock, Inc. 6.1% $135M 23.4M BlackRock, Inc. Dec 31, 2024
RA CAPITAL MANAGEMENT, L.P. 2% $44.5M 7.73M RA Capital Management, L.P. Dec 31, 2024
Kim Yohan 5.86% $1.54M 268K Yohan Kim Apr 4, 2025

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 324M $1.58B +$70.3M $4.88 313
2025 Q2 310M $1.57B +$26.5M $5.06 330
2025 Q1 304M $1.61B -$29.3M $5.29 330
2024 Q4 305M $2.06B +$292M $6.76 310
2024 Q3 261M $1.72B +$28.7M $6.59 263
2024 Q2 252M $1.89B +$323M $7.50 266
2024 Q1 210M $2.09B +$37.9M $9.97 242
2023 Q4 115K $1.16M -$1.94M $10.24 2
2023 Q3 149M $1.14B +$184M $7.65 186
2023 Q2 125M $931M -$5.48M $7.47 152
2023 Q1 126M $841M +$15M $6.67 156
2022 Q4 124M $954M +$135M $7.71 142
2022 Q3 112M $1.19B +$75.1M $10.64 137
2022 Q2 103M $842M +$96.4M $8.14 127
2022 Q1 94.8M $679M -$13.1M $7.16 119
2021 Q4 93.3M $1.6B +$283M $17.13 120
2021 Q3 54.9M $1.26B +$181M $23.01 82
2021 Q2 47M $1.71B +$1.71B $36.50 77
2021 Q1 30 $1K $0 $33.33 1
2020 Q4 30 $1K $0 $33.33 1
2020 Q3 30 $1K $0 $33.33 1
2020 Q2 30 $1K $0 $33.33 1
2020 Q1 30 $1K $0 $33.33 1
2019 Q4 30 $1K $0 $33.33 1
2019 Q3 30 $1K $0 $33.33 1
2019 Q2 30 $1K $0 $33.33 1
2019 Q1 30 $1K $0 $33.33 1